anayamalik, Author at European Medical Journal - Page 52 of 97

New Global Framework Targets Superbugs in Hospitals

Next-generation sequencing (NGS) for antimicrobial resistance (AMR) could revolutionize hospital infection control, according to a newly proposed global framework from a team of international infection prevention experts.

IFT Study Shares Fast-Acting Therapy for Acute Trigeminal Neuralgia: AAN 2025

Intravenous fosphenytoin (fPHT) demonstrated rapid and significant pain relief for patients experiencing acute exacerbations of trigeminal neuralgia (TN), according to late-breaking results from the IFT Study presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego.

Ide-Cel Shows 73% Response in Complex Multiple Myeloma Cases

In the treatment of relapsed/refractory multiple myeloma, CAR T-cell therapy using idecabtagene vicleucel (ide-cel) has demonstrated encouraging results in a large real-world U.S. patient cohort, according to new data from the CIBMTR registry.

How Does Tele-Nursing Help Mothers Manage Pediatric Epilepsy?

In a new quasi-experimental study aimed at improving pediatric epilepsy care, researchers have found that tele-nursing significantly reduces maternal anxiety and increases self-efficacy after hospital discharge.

Can Baby Illness Patterns Predict Future Asthma?

Infant symptoms such as wheezing, eczema, vomiting, and diarrhea in the first year of life may serve as early indicators of childhood asthma risk, according to a new study that offers promising insights into early identification strategies for the chronic respiratory disease.

TRAILBLAZER-ALZ Trial Data Reveals Donanemab Effects in Early Alzheimer's: AAN 2025

At the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego, new data from the TRAILBLAZER-ALZ clinical trial program highlighted critical risk factors and management strategies for amyloid-related imaging abnormalities (ARIA) in patients with early symptomatic Alzheimer’s disease treated with donanemab.

Landmark Migraine Study Identifies 778 Genetic Risk Variants in Veterans: AAN 2025

A genome-wide association study (GWAS) presented at the 2025 American Academy of Neurology (AAN) Annual Meeting in San Diego has identified 778 previously unknown genetic variants associated with migraine, shedding new light on the condition’s genetic underpinnings across racial and ethnic groups.

New Criteria Improve Diagnosis of IgG4-Related Arterial Disease

Healthcare professionals in the U.S. are closely watching progress in the diagnosis and management of IgG4-related periaortitis, periarteritis, and retroperitoneal fibrosis, a complex subset of IgG4-related disease (IgG4-RD) that mimics other conditions and defies simple diagnostic approaches.

Phototherapy Plus Antioxidants Top Vitiligo Treatments

In a new network meta-analysis evaluating treatments for vitiligo, researchers have identified the most effective combinations of phototherapy and topical therapies, offering clinicians fresh insights into optimizing patient outcomes.

Researchers Explore Stool Testing for Tuberculosis in HIV

In a multicenter prospective study, researchers found that a stool-based tuberculosis test could help detect TB in adults living with HIV, particularly among those with low CD4 counts.